Smoke Inhalation Injury in Patients Admitted to Intensive Care

Prognostic Factors for Smoke Inhalation Injury in Patients Admitted to Intensive Care

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03834246

Acronym

fumeintox

Enrollment

700

Registered

2019-02-07

Start date

2018-10-16

Completion date

2020-05-31

Last updated

2019-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morality, Smoke Inhalation Injury

Keywords

Prognostic Factors, intensive care unit

Brief summary

Many Studies have shown that the smoke-inhalation injury is responsible for a high mortality mainly related to the systemic effects of carbon monoxide and cyanide. Respiratory lesions induced by smoke inhalation, is one of predictive factors of mortality. The aim of the study is to identify the clinical and epidemiological characteristics of smoke-inhalation injury and to identify prognostic factors among these patients .

Detailed description

The study is a monocentric, retrospective, descriptive and analytical study , betwen december 1997 and september 2018 in intensive care unit of university of hospital. All patients aged over 18 year and who had received a diagnosis of smoke- inhalation injury and were admitted to the ICU of Medical University Hospital , a referral center in Paris providing HBO therapy , were potentially eligible for inclusion in this investigation. Criteria used for recommending HBO therapy to a patient with transient or prolonged unconsciousness, abnormal neurologic findings on physical examination. Data were analyzed to identify independent factors that may influence mortality.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men or women over the age of 18 * Hyperbaric oxygen therapy between 1997 and 2018

Exclusion criteria

* Patients under 18 years old. * Patient opposed to the use of his data * Patients not treated with hyperbaric oxygen

Design outcomes

Primary

Measure	Time frame	Description
mortality rate	20 years	survival study for the search of prognostic factors

Secondary

Measure	Time frame	Description
epidemiologic characteritics	20 years	description of quantitative and qualitative data

Countries

France

Contacts

Primary ContactRania BOUNAB, Dr

rania.bounab@aphp.fr+33 (1) 74 10 7778

Backup ContactFatima IZEDAREN, CRA

fatima.izedaren@aphp.fr+33 (1) 47 10 44 49

Outcome results